Researchers at the Joslin Diabetes Center identified insulin resistance in the liver as a key factor in metabolic syndrome and associated artheroschlerosis disorders.
Good to see this little insight hitting the mainstream press at last:
“This is one of the first true insights into the role of the liver in the metabolic syndrome and provides guidance for future therapies,’’ said senior investigator Dr. Kahn, an internationally recognized researcher in diabetes and metabolism. “Showing this connection between atherosclerosis and insulin resistance is one of the most dramatic findings I’ve seen in 35 years.’’
My friend, Dr. Hugo Rodier, has been successfully treating metabolic syndrome patients for years by addressing insulin resistance and liver health, but he's consistently ahead of his time clinically.
Meanwhile, did you know that metabolic syndrome affects approximately a quarter of all Americans and a growing number of children, all of whom suffer from diverse maladies because, at the cellular level, insulin signalling has gone awry?
What to do? Drop the weight. Increase exercise. Improve your diet. And, also, increase your intake of protective agents that reduce inflammation and support liver health and healthy cellular communication.